Skip to main content

Karen Segura Dávila

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Karen Segura Dávila

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Helena Llonch Valsells

Helena Llonch Valsells

Administration and Management
Psychiatry, Mental Health and Addictions
Read more
Sofía Travers Rama

Sofía Travers Rama

Predoctoral researcher
Gene and Cell Therapy
Read more
Victor Bernabe Perez

Victor Bernabe Perez

Gestió i Administració
Software Engineering Unit
Digital Transformation Directorate
Read more
Mariana Perez Cano

Mariana Perez Cano

Research technician
Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.